FASANO, Mauro

FASANO, Mauro  

Dip. CHIMICA I.F.M (attivo dal 01/01/1900 al 31/12/2011)  

Mostra records
Risultati 1 - 20 di 33 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autore(i) File
A New Ytterbium Chelate as Contrast Agent in Chemical Shift Imaging and Temperature Sensitive Probe for MR Spectroscopy 1996 S.AIME; M. BOTTA; M. FASANO; E. TERRENO; P. KINCHESH; L. CALABI; L. PALEARI
Alpha-synuclein and Parkinson's disease: a proteomic view. 2008 M. Fasano;L. Lopiano
Binding and relaxometric properties of heme complexes with cyanogen bromide fragments of human serum albumin 2002 Monzani E; Curto M; Galliano M; Minchiotti L; Aime S; Baroni S; Fasano M; Amoresano A; Salzano AM; Pucci P; Casella L
Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated. 2010 G. Fanali;V. Rampoldi;A. d. Masi;A. Bolli;L. Lopiano;P. Ascenzi;M. Fasano
Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment. 2010 T. Alberio;M. Colapinto;M. Natale;R. Ravizza;M. B. Gariboldi;E. M. Bucci;L. Lopiano;M. Fasano
EFFECT OF IBUPROFEN AND WARFARIN ON THE ALLOSTERIC PROPERTIES OF HAEM-HUMAN SERUM ALBUMIN 2001 BARONI S.; MATTU M.; VANNINI A.; CIPOLLONE R.; S. AIME; ASCENZI P.; FASANO M.
Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra. 1994 AIME S ;FASANO M ;BERGAMASCO B ;LOPIANO L ;VALENTE G
Expression proteomics of peripheral blood lymphocytes from Parkinson's disease patients 2006 Mila S; Albo AG; Corpillo D; Zibetti M; Bergamasco B ; Lopiano L ; Fasano M.
Gd(III) Complexes as Contrast Agents for Magnetic Resonance Imaging: a Proton Relaxation Enhancement Study of the Interaction with Human Serum Albumin 1997 S. AIME; M. BOTTA; M. FASANO; S. GENINATTI CRICH; E. TERRENO
Ln(III) Chelates for NMR Biomedical Applications 1998 S. AIME; M. BOTTA; M. FASANO; E. TERRENO
Low noncarbonic buffer power amplifies acute respiratory acid-base disorders in patients with sepsis: An in vitro study 2021 Langer T.; Brusatori S.; Carlesso E.; Zadek F.; Brambilla P.; Fusarini C.F.; Duska F.; Caironi P.; Gattinoni L.; Fasano M.; Lualdi M.; Alberio T.; Zanella A.; Pesenti A.; Grasselli G.
Lymphocyte proteomics of Parkinson’s disease patients reveals cytosckeletal protein dysregulation and oxidative stress 2009 S. Mila; A. Giuliano Albo; D. Corpillo; S. Giraudo; M. Zibetti; E. M. Bucci; L. Lopiano; M. Fasano
Magnetic investigations of human mesencephalic neuromelanin 2002 BOLZONI F; GIRAUDO S; L. LOPIANO; BERGAMASCO B; FASANO M; CRIPPA PR
Metal ion content in Sepia officinalis melanin 1992 C. Sarzanini; E. Mentasti; O. Abollino; M. Fasano; S. Aime
Modulation of the antioxidant activity of HO center dot scavengers by albumin binding: a F-19-NMR study 2003 S. AIME; DIGILIO G.; BRUNO E.; MAINERO V.; BARONI S.; FASANO M.
Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation. 2000 LOPIANO L.; FASANO M.; GIRAUDO S.; DIGILIO G.; KOENIG S.H.; TORRE E.; B. BERGAMASCO; AIME S.
Nuclear magnetic resonance spectroscopy characterization and iron content determination of human mesencephalic neuromelanin. 1996 AIME S ;FASANO M ;BERGAMASCO B ;LOPIANO L ;QUATTROCOLO G
Paramagnetic Gd(III)-Fe(III) Heterobimetallic Complexes of DTPA-Bis-Salicylamide 1993 S. AIME; M. BOTTA; M. FASANO; E. TERRENO
Paramagnetic water proton relaxation enhancement: From contrast agents in MRI to reagents for quantitative “in vitro” assays 1992 S. Aime; M. Botta; G. Ermondi; M. Fasano; E. Terreno
Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration. 2008 M. Fasano;T. Alberio;L. Lopiano